ACSL (6232) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
18 Aug, 2025Executive summary
Q1 net sales rose 142% year-over-year to 700 mn JPY, driven by large ATLA and US orders, with order backlog reaching 1.37 bn JPY.
Operating loss narrowed to 239 mn JPY, and ordinary loss to 16 mn JPY, both improving significantly due to cost reductions and subsidy income.
Structural reforms and reduced R&D and SG&A expenses supported improved profitability.
Management transition to Co-CEOs Hayakawa and Terayama aims to enhance agility and sustainable growth.
Comprehensive income loss improved to 24 mn JPY from 653 mn JPY year-over-year.
Financial highlights
Q1 gross profit: 75.9 mn JPY (up from 36.4 mn JPY YoY); gross profit margin: 11% (down 2pt YoY).
SG&A expenses (excluding gov. projects) reduced by 192 mn JPY YoY; R&D expenses for existing projects significantly lowered.
Operating expenses decreased to 315 mn JPY from 631 mn JPY YoY.
Cash and equivalents at Q1 end: 2 bn JPY; total assets increased to 5,421 mn JPY as of March 31, 2025.
Basic earnings per share improved to (1.12) JPY from (45.06) JPY YoY.
Outlook and guidance
FY25 full-year net sales forecast: 5,110 mn JPY (+2,454 mn JPY YoY); gross profit: 1,630 mn JPY (32% margin).
Targeting return to profitability in operating and net profit, excluding government project expenses.
Basic earnings per share for the full year expected to be 1.96 JPY.
Local government projects to contribute 2 bn JPY in sales; US market share to rise to 30–40% of existing business.
Mid-term targets: existing business CAGR >20%, gross profit margin >40% by FY27.
Latest events from ACSL
- Revenue up 68.9% YoY, but net loss persists amid fraud-related costs and higher expenses.6232
Q2 2026 - Q1 revenue fell 12% YoY, but gross margin surged and defense orders drove backlog growth.6232
Q1 2026 - Losses narrowed, equity strengthened, and FY26 forecasts strong sales growth and margin gains.6232
Q4 2025 - FY25 revenue grew to JPY 2.59 bn, with strong U.S. and defense sector expansion and improved margins.6232
Investor presentation - Sales revised down on U.S. delays, but losses narrowed and guidance remains cautious.6232
Q3 2025 - Sales soared 291% year-over-year, but losses deepened despite improved gross margin.6232
Q2 2024 - Sales up 224% YoY, backlog strong, but heavy losses and capital adequacy fell.6232
Q3 2024 - Sales soared 196% YoY, but losses and capital adequacy concerns remain.6232
Q4 2024 - Revenue and backlog rose YoY, but sales fell and losses narrowed amid project delays.6232
Q2 2025